Enhanced Protection from SARS-CoV-2 Variants by MVA-Based Vaccines Expressing Matched or Mismatched S Proteins Administered Intranasally to hACE2 Mice https://www.biorxiv.org/content/10.1101/2022.12.03.518963v1?med=mas
Enhanced Protection from SARS-CoV-2 Variants by MVA-Based Vaccines Expressing Matched or Mismatched S Proteins Administered Intranasally to hACE2 Mice https://www.biorxiv.org/content/10.1101/2022.12.03.518963v1?med=mas